Title here

Text here
 

LUDWIG INSTITUTE FOR CANCER RESEARCH Organization Name provided in the GuideStar Exchange* as of 06/08/2012: LUDWIG INSTITUTE FOR CANCER RESEARCH

Organization Name as listed in the IRS Business Master File as of 06/09/2014: LUDWIG INSTITUTE FOR CANCER RESEARCH

* The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

AKA  LICR
New York, NY
GuideStar Exchange - Silver Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

GuideStar Summary

&1002; GuideStar Exchange Committed to transparency ?
This organization is a Silver-level GuideStar Exchange participant, demonstrating its commitment to transparency.

Is this your nonprofit? Update your information today!
&1002; Registered with IRS Legitimacy information is available
&1002; Financial Data Annual Revenue and Expense data reported
&1002; Forms 990 2012, 2011, and 2010 Forms 990 filed with the IRS
&1002; Mission Objectives Mission Statement is available
&1002; Impact Summary Impact Summary from the nonprofit is available
  No Personal Reviews available No Personal Reviews available | Write a Review

Basic Organization Information

LUDWIG INSTITUTE FOR CANCER RESEARCH Organization Name provided in the GuideStar Exchange* as of 06/08/2012: LUDWIG INSTITUTE FOR CANCER RESEARCH

Organization Name as listed in the IRS Business Master File as of 06/09/2014: LUDWIG INSTITUTE FOR CANCER RESEARCH

* The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
Also Known As: LICR
Physical Address: New York, NY 10017 
EIN: 23-7121131
Web URL: www.licr.org 
NTEE Category: H Medical Research
H30 Cancer Research
H Medical Research
H05 Research Institutes and/or Public Policy Analysis
Ruling Year: 1971 
How This Organization Is Funded: LICR Fund Inc - supporting organization - $57,000,000
Government Grants - $25,000,000
Other - $19,000,000


Sign in or create an account to see this organization's full address, contact information, and more!

Mission Statement

The Ludwig Institute for Cancer Research Ltd is committed to improving the understanding and control of cancer through integrated laboratory and clinical discovery. Leveraging its worldwide network of investigators and the ability to sponsor and conduct its own clinical trials, the Institute is actively engaged in translating its discoveries into applications for human benefit.

Legitimacy Information

This organization is registered with the IRS.

This organization is required to file an IRS Form 990 or 990-EZ.

Institutional funders should note that an organization’s inclusion on GuideStar.org does not satisfy IRS Rev. Proc. 2011-33 for identifying supporting organizations.

Learn more about GuideStar Charity Check, the only pre-grant due diligence tool that is 100% compliant with IRS Rev. Proc 2011-33.

GuideStar Exchange - Silver Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Annual Revenue & Expenses (IRS Form 990, January 2012)

Fiscal Year Starting: January 01, 2012
Fiscal Year Ending: December 31, 2012

Total Revenue $123,246,281
Total Expenses $113,956,738

Revenue & Expenses

Revenue and expense information has not been provided by the nonprofit. Click here if you are associated with this organization and want to provide this information.

Chart Illustration Revenue and Expense data from Forms 990 for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Back to Top »

Balance Sheet (IRS Form 990)

Chart Illustration Balance Sheet data from Forms 990 for Year 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Back to Top »
GuideStar Exchange - Silver Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Forms 990 Received from the IRS Additional Information
IRS Form 990 is an annual document used by approximately one-third of all public charities to report information about their finances and operations to the federal government. GuideStar uses data from Form 990 to populate its database with financial information about nonprofit organizations. Posting Form 990 images on the GuideStar website is an ongoing process.

Sign in or create an account to view Form(s) 990 for 2012, 2011, 2010.

Chart Illustration Forms 990 for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Forms 990 Provided by the Nonprofit

Sign in or create an account to view Form(s) 990 for 2009, 2008, 2007.

Financial Statements

Chart Illustration Financial Statements for 2009, 2008, 2007 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Annual Reports

Sign in or create an account to view this information.

GuideStar Exchange - Silver Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Leadership

(GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
June 2012)

Mr. Edward A. McDermott, Jr

Term:

Since Jan 2006

Board Chair (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
June 2012)

Sign in or create an account to view this information from the GuideStar Exchange

Board Co-Chair

This information has not been provided by the nonprofit. Click here if you are associated with this organization and want to provide this information.

Board of Directors (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
June 2012)

Sign in or create an account to view this information from the GuideStar Exchange

Board Leadership Practices (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
June 2012)
?

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section, which enables organizations and donors to transparently share information about essential board leadership practices.

Board Orientation & Education ?
Why does this matter? Without clarity around their responsibilities and expectations, board members are not positioned to succeed. They may find themselves challenged to fulfill their governance responsibilities or frustrated by the expectations that the organization has set for them. BoardSource recommends that every new board member participate in a formal orientation process, and that all board members sign a pledge or agreement committing to their board service and to all of the responsibilities and expectations that come with service. Ideally, board members also should participate in a formal governance training program prior to serving on a board.

Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations?
Response Not Provided
CEO Oversight ?
Why does this matter? Oversight and management of the chief executive is one of the board’s most important legal responsibilities. The CEO or executive director is the board's single employee, and - just like any other employer/employee relationship - regular and written assessment is critical to ensuring that the chief executive and board are communicating openly about goals and performance. BoardSource recommends that boards conduct formal, written reviews of their chief executives on an annual basis, which should include an in-person discussion with the chief executive and distribution of the written evaluation to the full board.

Has the board conducted a formal, written assessment of the chief executive within the past year?
Response Not Provided
Ethics & Transparency ?
Why does this matter? A commitment to handling conflicts of interests is essential to creating an organizational culture of transparency. Boards should create and follow a policy for identifying and handling conflicts of interest, whether real or perceived. BoardSource recommends that organizations review the conflict-of-interest statement and require signed disclosures from all board members and senior staff on an annual basis.

Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements within the past year?
Response Not Provided
Board Composition ?
Why does this matter? The best boards are composed of individuals who bring a variety of skills, perspectives, backgrounds, and resources to tackle the complex and strategic challenges confronting their organizations. BoardSource recommends that boards commit to diversity and inclusion by establishing written policies and practices, which include strategic and intentional recruitment of diverse board members, continual commitment to inclusivity, and equal access to board leadership opportunities.

Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership?
Response Not Provided
Board Performance ?
Why does this matter? Boards need to regularly assess their own performance. Doing so ensures that they are being intentional about how they govern their organization, which is a critical component of effective board leadership. BoardSource recommends that a board conduct a self-assessment of its performance a minimum of once every three years to ensure that it is staying on track with its roles and responsibilities.

Has the board conducted a formal, written self-assessment of its performance within the past three years?
Response Not Provided

Officers for Fiscal Year (IRS Form 990)

Chart Illustration Officers for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Highest Paid Employees & Their Compensation (IRS Form 990)

Chart Illustration Highest Paid Employee Data for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

People information was last updated by the nonprofit in June 2012

Click here if you are associated with this organization and want to provide updated information.

GuideStar Exchange - Silver Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Programs

Program: (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
June 2012)

Budget:
--
Category:
Population Served:

Program Description:

Multi-disciplinary international research. The two major programs are: "Laboratory Research," in which investigator-initiated research projects further our understanding of cancer, and; "Clinical Research," in which the therapeutic potential of LICR discoveries are explored in clinical trials conducted and sponsored by LICR.

Program Long-Term Success:

Identified a molecular signature that predicts a patient's prognosis following diagnosis of Stage IV melanoma.

Program Short-Term Success:

Program Success Monitored by:

Program Success Examples:

Program: Laboratory Research Leading to Clinical Applications (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
June 2012)

Budget:
$88,800,000
Category:
Medical Research
Population Served:
Adults

Program Description:

The prospects for controlling cancer will only improve through an ongoing commitment to innovative research that has a singular focus on the understanding of cancer onset and progression, and the identification and characterization of tools and targets for new prognostic, diagnostic and therapeutic modalities. The Ludwig Institute for Cancer Research Ltd (LICR) engages leading scientists and clinicians in an integrated laboratory and clinical research effort to understand and confront the global challenge of cancer. LICR laboratory research seeks to extend our knowledge of genes, proteins, cells and cellular processes involved in cancer onset and progression. This understanding of the macromolecular and cellular aberrations in cancer then allows LICR investigators to further their laboratory work to identify, characterize and test new tools and targets for their potential as clinical applications. Substantially all laboratory research financed by LICR is carried out by the Institute’s own appointed research staff or through research collaborations involving LICR staff and external investigators. The research staffs of the Institute are organized in Branches with one Branch each in Belgium, Brazil, Switzerland and the UK, and two each in Australia, Sweden and the USA. The Institute employs around 780 scientists, clinicians and support personnel, with each Branch staffed to ensure that complex cancer research problems can be addressed by a critical mass of investigators having expertise in several scientific disciplines. The Branches have been established in association with a leading non-profit university, hospital and/or research institute to facilitate close collaboration between laboratory and clinical scientists and to provide access to the widest range of scientific, technological and clinical resources. With ten Branches in seven countries across Australasia, Europe, and North and South America, and numerous Affiliates in ten other countries, the LICR network quite literally covers the globe. LICR is distinguishable from other cancer research institutes, not only by its size and global reach, but also by its reliable, long-term funding perspective. A limitation of the academic medical research—in which funding is given to individual investigators by government agencies and not the investigator’s academic institution—is that research projects are too frequently fragmented, overlapping, and lacking in strategic coordination. Research also becomes predominantly defined by what can be achieved in a single laboratory within a funding cycle of, typically, three years. In contrast, LICR funds over 70% of the cost of the research that it conducts; support that is drawn from the Institute’s endowment and from donations. This reliable and flexible funding model gives LICR investigators the freedom to tackle speculative, long-term research, and encourages and enables multidisciplinary teams of investigators to tackle larger, more complex cancer challenges. A vast amount of our understanding about cancer has come from the detailed and systematic analysis of the structure, function and relationships of single molecules. Although there is still much to be learned from this approach, LICR believes it is imperative to also study individual tumor types in order to make continued and substantive progress in our understanding and control of cancer. We now know that the term “cancer” encompasses a range of different diseases, and that there can be substantial differences in disease progression and/or treatment response between individuals with any one type of cancer. We also now know that tumors are composed of multiple, whole humancells and must be considered as organs having their own tissue structure and environment. LICR has thus established Cancer Initiatives through which LICR investigators and Affiliates are focusing their expertise drawn from multiple research fields on specific cancer types. Currently the Institute has Brain, Breast, Colon and Ovarian Cancer Initiatives and a Melanoma Initiative. The protection and licensing of intellectual property (IP) generated by research discoveries are fundamental to LICR’s commitment to translate its discoveries into applications for human benefit. Without a proprietary position, for-profit companies will not invest in the clinical development, manufacture, distribution, marketing and sales required to translate LICR discoveries into new therapies for cancer patients. Accordingly, LICR patents its discoveries such that its IP is managed for public benefit; the IP is made freely-available to the academic research community, and a financial return can be expected for the company that invests in the therapy’s successful development and, potentially, for LICR to fund further research efforts. In 2008, LICR investigators published 250 primary research articles and 58 reviews, book chapters and/or commentaries. These publications covered a range of cancer research discoveries in the fields of genetics, genomics, cell biology, signal transduction, proteomics, immunology, bioinformatics, and targeted therapy development. In 2008, 18 patents were issued and 31 were filed in the USA based on LICR discoveries, and a further 15 new international patent applications were filed as well. These patents cover research discoveries relating to growth factors, cytokines, signaling molecules, antibodies and human tumor antigens.

Program Long-Term Success:

Program Short-Term Success:

Program Success Monitored by:

Program Success Examples:

Program: Clinical Research (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
June 2012)

Budget:
$15,500,000
Category:
Diseases, Disorders & Medical Disciplines
Population Served:
Adults

Program Description:

Laboratory research on isolated cells and macromolecules will not alone produce the diagnostic and therapeutic modalities required for cancer control. To further understand the disease and the body’s reaction to it, and to explore the therapeutic potential of discoveries, clinical research—the analysis of patient samples and potential therapies in clinical trials—must also be conducted. Recognizing this, LICR takes responsibility for the entire discovery continuum, from the laboratory to the clinic. Many universities and academic research institutes lack the expertise, infrastructure and resources to introduce their laboratory discoveries into the clinic. To bridge that divide they turn their work product over to companies that engage in drug development, a process driven by primarily commercial considerations: time to product launch and share of market captured. Between the worlds of laboratory discovery and therapeutic utility, there is a missing link that interrupts the efficient exploration of knowledge for human benefit. That missing link is clinical research. LICR is convinced that the same systematic, investigative rigor that yielded the laboratory discovery in the first place should be applied in early-phase clinic trials to assess a discovery’s therapeutic potential. The Institute has, therefore, committed the resources and marshaled the capabilities that allow it to evaluate its promising basic discoveries in first-in-man clinical studies. LICR has licensing interactions with biotechnology and pharmaceutical companies that allow the Institute to obtain proprietary reagents and clinically evaluate whether these reagents might complement the therapeutic potential of the Institute’s own discoveries. LICR’s interactions with industry are designed to protect the ethos and integrity of the Institute and to ensure that its discoveries are actively pursued as prognostic, diagnostic and/or therapeutic agents for human benefit. In 2008, LICR initiated three new trials, bringing to 17 the number of open clinical trials it is conducting. By the end of 2008, a total of 134 patients were enrolled in LICR-sponsored clinical trials, and the Institute had 12 active Investigational New Drug (IND) applications (USA), two Drug Master Files (DMF) and two Investigational Medicinal Product Dossiers (EU). The Institute’s current clinical trials are investigating potential therapies that are based on targeted antibody, cancer vaccine, and enzyme-depletion therapeutic strategies.

Program Long-Term Success:

Program Short-Term Success:

Program Success Monitored by:

Program Success Examples:

GuideStar Exchange - Silver Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Impact Summary from the Nonprofit

LICR is distinguishable from other cancer research institutes, not only by its size and global reach, but also by two fundamental attributes: its flexible, long-term funding perspective and the fact that it takes responsibility for the full spectrum of research from the laboratory to the clinic.
GuideStar Exchange - Silver Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Reviews

GuideStar Exchange - Silver Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Contractor data is available for this organization!

Independent Contractor information for 2012, 2011, 2010, 2009, 2008 is available for this organization with a subscription to GuideStar Premium Pro.

GuideStar Premium Pro also includes:

  • Comprehensive financial data, including functional expense detail, for every digitized fiscal year in GuideStar's database
  • Ability to download up to 55 fields of data for up to 1,000 organizations at a time and up to five years’ worth of Income Statement and Balance Sheet data for individual organizations
  • Comprehensive advanced search capabilities, including criteria for functional expenses, investible assets, investment income and audit & 990T filing requirements
  • Ability to save organizations and searches for quick reference
  • People search with salary range data
  • Access to all available Forms 990

More information

Upgrade Now!

Organization Data Available

Adobe PDF Format A GuideStar Premium Report in PDF format is available for this organization

Price for this Report: $125.00

This Premium Report includes:

  • Financial Data for
  • Financial Charts for
  • Forms 990 for
  • Forms 990T for
  • Audited Financial Statement for
  • Annual Reports for
  • Letter of Determination
  • Form 1023 / 1024
  • Board Members
  • Officer, Director and/or Highest Paid Employee data for


Learn more about GuideStar Premium